MLYS
Mineralys Therapeutics Inc.
$31.56
+$0.69(+2.24%)
37
Overall
50
Value
20
Tech
42
Quality
Market Cap
$2.60B
Volume
1.83M
52W Range
$8.24 - $47.65
Target Price
$50.88
Key Metrics Overview
| Market Cap | $2.60B | P/E Ratio | N/A |
| 52W High | $47.65 | 52W Low | $8.24 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | N/A | 52W Position | 59.2% |
| Overall Score | 37 | Value Score | 50 |
| Quality Score | 42 | Technical Score | 20 |
Growth Analysis
| EPS Current Est | $-2.44 | EPS Next Est | $-2.5 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
No data available
EBITDA (5Y)
No data available
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MLYS | $31.56 | +2.2% | 1.83M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Mineralys Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW